Join
Live feed
·
PRReleasevia Quantisnow
Alimera Sciences Inc. logo
ANI Pharmaceuticals Inc. logo

ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences

ByQuantisnow·Wall Street's wire, on your screen.
ALIM· Alimera Sciences Inc.ANIP· ANI Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALIM (Alimera Sciences Inc.), ANIP (ANI Pharmaceuticals Inc.) and more on Quantisnow.